mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.06 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.06 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.07 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.07 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |